Skin Protective Composition, And Implementation Thereof

Itc Limited
Hearing App No 201941012741 Chemical

Patent information

IP India · live record
Application number
201941012741
Filing date
29 March 2019
Status
Hearing
Publication number
40/2020
Publication type
INA
Invention field
Chemical

Abstract

The present disclosure discloses a composition comprising: (a) Morns alba root extract; (b) Moringa oleifera seed extract; and (c) Vitis vinifera seed extract, wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 0.5-2:0.5-2:0.5-2. The composition as disclosed herein provides protection to the skin by inhibiting the production of ROS during exposure to the harmful radiations.

Applicants

1
India
ITC LIMITED ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore

Inventors

6
India
MUTHAIYAH, BaluITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
India
VIJAYAN, Santhosh VirenITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
India
BANDYOPADHYAY, BalajiITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
India
KALSI, GurpreetITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
India
RAMAMURTHI, SureshITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058
India
CHANDRASEKHARAN, Lakshmanan ChitturITC Life Sciences and Technology Centre, Peenya Industrial Area, Ist Phase, Bangalore-560 058

Claims

9
1 A composition comprising: a) Morus alba root extract; b) Moringa oleifera seed extract; and c) Vitis vinifera seed extract, wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 0.5-2:0.5-2:0.5-2.
2 The composition as claimed in claim 1, wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 1:1:1.
3 The composition as claimed in claim 1, wherein the Morus alba root extract has a weight percentage in a range of 0.005-0.02% with respect to the composition.
4 The composition as claimed in claim 1, wherein the Moringa oleifera seed extract has a weight percentage in a range of 0.005-0.02% with respect to the composition.
5 The composition as claimed in claim 1, wherein the Vitis vinifera seed extract has a weight percentage in a range of 0.005-0.02%) with respect to the composition.
6 The composition as claimed in claim 1, wherein the Morus alba root extract has a weight percentage of 0.01% with respect to the composition, the Moringa oleifera seed extract has a weight percentage of 0.01% with respect to the composition, and the Vitis vinifera seed extract has a weight percentage of 0.01% with respect to the composition.
7 The composition as claimed in claim 1, wherein the Morus alba root extract comprises oxyresveratrol in a weight percentage in a range of 0.5%-2 % with respect to the extract, the Moringa oleifera seed extract comprises saponin in a weight percentage in a range of 0.1%-0.5% with respect to the extract, and the Vitis vinifera seed extract comprises proanthocyanidin in a weight percentage in a range of 0.1%-0.5% with respect to the extract.
8 A process for preparing the composition as claimed in claim 1, said process comprising: a) obtaining Morus alba root extract; b) obtaining Moringa oleifera seed extract; c) obtaining Vitis vinifera seed extract; and d) contacting the Morus alba root extract, the Moringa oleifera seed extract, and the Vitis vinifera seed extract, to obtain the composition.
9 The composition as claimed in any one of the claims 1-7, wherein the composition inhibits production of reactive oxygen species (ROS).

Specification

Show full textCollapse

I/We Claim: 1. A composition comprising: a) Morus alba root extract; b) Moringa oleifera seed extract; and c) Vitis vinifera seed extract, wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 0.5-2:0.5-2:0.5-2. 2. The composition as claimed in claim 1, wherein the Morus alba root extract to the Moringa oleifera seed extract to the Vitis vinifera seed extract weight ratio is in a range of 1:1:1. 3. The composition as claimed in claim 1, wherein the Morus alba root extract has a weight percentage in a range of 0.005-0.02% with respect to the composition. 4. The composition as claimed in claim 1, wherein the Moringa oleifera seed extract has a weight percentage in a range of 0.005-0.02% with respect to the composition. 5. The composition as claimed in claim 1, wherein the Vitis vinifera seed extract has a weight percentage in a range of 0.005-0.02%) with respect to the composition. 6. The composition as claimed in claim 1, wherein the Morus alba root extract has a weight percentage of 0.01% with respect to the composition, the Moringa oleifera seed extract has a weight percentage of 0.01% with respect to the composition, and the Vitis vinifera seed extract has a weight percentage of 0.01% with respect to the composition. 7. The composition as claimed in claim 1, wherein the Morus alba root extract comprises oxyresveratrol in a weight percentage in a range of 0.5%-2 % with respect to the extract, the Moringa oleifera seed extract comprises saponin in a weight percentage in a range of 0.1%-0.5% with respect to the extract, and the Vitis vinifera seed extract comprises proanthocyanidin in a weight percentage in a range of 0.1%-0.5% with respect to the extract.

8. A process for preparing the composition as claimed in claim 1, said process comprising: a) obtaining Morus alba root extract; b) obtaining Moringa oleifera seed extract; c) obtaining Vitis vinifera seed extract; and d) contacting the Morus alba root extract, the Moringa oleifera seed extract, and the Vitis vinifera seed extract, to obtain the composition. 9. The composition as claimed in any one of the claims 1-7, wherein the composition inhibits production of reactive oxygen species (ROS).

Documents

Sign in to open
Application documents
1 201941012741-STATEMENT OF UNDERTAKING (FORM 3) [29-03-2019(online)].pdf 29 Mar 2019
2 201941012741-FORM 1 [29-03-2019(online)].pdf 29 Mar 2019
3 201941012741-DRAWINGS [29-03-2019(online)].pdf 29 Mar 2019
4 201941012741-DECLARATION OF INVENTORSHIP (FORM 5) [29-03-2019(online)].pdf 29 Mar 2019
5 201941012741-COMPLETE SPECIFICATION [29-03-2019(online)].pdf 29 Mar 2019
6 201941012741-Proof of Right (MANDATORY) [25-06-2019(online)].pdf 25 Jun 2019
7 201941012741-FORM-26 [25-06-2019(online)].pdf 25 Jun 2019
8 Correspondence by Agent_Form1 And Power of Attorney_27-06-2019.pdf 27 Jun 2019
9 201941012741-FORM 18 [06-03-2023(online)].pdf 06 Mar 2023
10 201941012741-FER.pdf 12 Oct 2023
11 201941012741-OTHERS [11-04-2024(online)].pdf 11 Apr 2024
12 201941012741-FER_SER_REPLY [11-04-2024(online)].pdf 11 Apr 2024
13 201941012741-Response to office action [04-07-2024(online)].pdf 04 Jul 2024
14 201941012741-US(14)-HearingNotice-(HearingDate-29-08-2025).pdf 04 Aug 2025
15 201941012741-FORM-26 [20-08-2025(online)].pdf 20 Aug 2025
16 201941012741-Correspondence to notify the Controller [26-08-2025(online)].pdf 26 Aug 2025
17 201941012741-Written submissions and relevant documents [11-09-2025(online)].pdf 11 Sep 2025
Search strategy
1SearchHistoryE_11-10-2023.pdf
2201941012741_SearchStrategyAmended_E_Skin_Morus_VitiAE_30-07-2025.pdf